Read More Pharma Industry News ProteKt secures funding for PKR kinase inhibitor-based therapies Israeli biotech company ProteKt Therapeutics, which is focused on developing new PKR kinase inhibitor-based therapies for Alzheimer’s Disease… bypharmanewsdailyNovember 13, 2019